March 05, 2020 Biopharma’s role in tackling coronavirus The industry has a duty to develop Covid-19 antivirals and vaccines, but the nature of clinical trials means that lower-profile measures must take precedence.
July 02, 2018 June rush drives near-record quarter for biotech flotations Biotech IPOs raised a huge $2.3bn on Western exchanges in the second-quarter of 2018, as private companies rushed to market ahead of the summer lull.
